tbuckley/cabot-search huggingface dataset:
Chiropractic
Authors: Edzard Ernst
Journal: Annals of Internal Medicine (2002)

Letters15 October 2002ChiropracticEdzard Ernst, MD, PhD, FRCP(Edin)Edzard Ernst, MD, PhD, FRCP(Edin)University of Exeter; Exeter, Devon EX2 4NT, United KingdomSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-8-200210150-00025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The article by Meeker and Haldeman (1) on chiropractic is highly informative on several issues but equally misleading on other points, particularly research. For instance, the authors state that there is no evidence of publication bias in the chiropractic literature. We have recently shown that, in the United Kingdom, nonpublication of severe adverse effects of chiropractic seems to be close to 100% (2). The authors also claim that 43 randomized, controlled trials of spinal manipulation for back pain have been published, but they fail to mention that most of them do not relate to chiropractic spinal manipulation.... References1. Meeker WC, Haldeman S. Chiropractic: a profession at the crossroads of mainstream and alternative medicine. Ann Intern Med. 2002;136:216-27. [PMID: 11827498] LinkGoogle Scholar2. Stevinson C, Honan W, Cooke B, Ernst E. Neurological complications of cervical spine manipulation. J R Soc Med. 2001;94:107-10. [PMID: 11285788] CrossrefMedlineGoogle Scholar3. Brox JI, Hagen KB, Juel NG, Storheim K. [Is exercise therapy and manipulation effective in low back pain?]. Tidsskr Nor Laegeforen. 1999;119:2042-50. [PMID: 10394281] MedlineGoogle Scholar4. van Tulder MW. Low back pain and sciatica. Clinical Evidence. 1999;2:406-22. Google Scholar5. Olafsdottir E, Forshei S, Fluge G, Markestad T. Randomised controlled trial of infantile colic treated with chiropractic spinal manipulation. Arch Dis Child. 2001;84:138-41. [PMID: 11159288] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Exeter; Exeter, Devon EX2 4NT, United Kingdom PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoChiropractic: A Profession at the Crossroads of Mainstream and Alternative Medicine William C. Meeker and Scott Haldeman Chiropractic Daniel J. Fink Chiropractic Ludmil A. Chotkowski Chiropractic William C. Meeker and Scott Haldeman Chiropractic Ronald L. Fredrickson Metrics 15 October 2002Volume 137, Issue 8Page: 701KeywordsAdverse eventsChiropracticFatigueHeadachesLower back painSystematic reviews ePublished: 15 October 2002 Issue Published: 15 October 2002 CopyrightCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Medical Heuristics
Authors: William J. Oetgen
Journal: Annals of Internal Medicine (1996)

Letters1 July 1996Medical HeuristicsWilliam J. Oetgen, MD, MBAWilliam J. Oetgen, MD, MBAGeorgetown University, Washington, DC 20007Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-125-1-199607010-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Dr. McDonald's recent essay on medical heuristics is interesting and timely. His thesis that a critical review to clarify, improve, and standardize medical heuristics could reduce practice variation and optimize the care process deserves serious consideration. After all, the reduction of practice variation is an activity that consumes increasing amounts of our time. But where do these heuristics come from? How can they be collected for clarification, improvement, and standardization?Perhaps a place to begin is with a collection of house officer aphorisms that, on reflection, seem to be one of the ways that heuristics are passed ...References1. McDonald CJ. Medical heuristics: the silent adjudicators of clinical practice. Ann Intern Med. 1996; 124:56-62. Google Scholar2. Stein RS. CPR-not-indicated and futility [Letter]. Ann Intern Med. 1996; 124:75. Google Scholar3. Lenert LA, Markowitz DR, Blashke TF. Primum non nocere? Valuing of the risk of drug toxicity in therapeutic decision making. Clin Pharmacol Bull. 1988; 24:285-91. Google Scholar Author, Article, and Disclosure InformationAuthors: William J. Oetgen, MD, MBAAffiliations: Georgetown University, Washington, DC 20007 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoMedical Heuristics: The Silent Adjudicators of Clinical Practice Clement J. McDonald Medical Heuristics: The Silent Adjudicators of Clinical Practice Clement J. McDonald Medical Heuristics Donald A. Gerber Metrics Cited byFièvres prolongées inexpliquées : tactique, stratégie 1 July 1996Volume 125, Issue 1Page: 77-78KeywordsCardiopulmonary resuscitationHealth care ePublished: 15 August 2000 Issue Published: 1 July 1996 Copyright & PermissionsCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Deaths and Obituaris.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Flucytosine
Authors: John P. Utz
Journal: New England Journal of Medicine (1972)

This week flucytosine (5-FC) will be released to the medical profession. It is the first new drug in approximately 15 years with activity in the systemic mycoses. The occasion prompts the following observations and caveats.The range of infections treatable with 5-FC is remarkably limited: from animal and human studies candida species and Cryptococcus neoformans. A less frequently pathogenic yeast, Torulopsis glabrata, is sensitive in vitro, and success has been claimed in three of five cases reported so far. In animal infections chemotherapeutic activity has been found against Aspergillus fumigatus, but no clinical data encountered so far . . .
Multidisciplinary approach aids successful swallowing
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TCT-486 Long-Term Comparison of Percutaneous Coronary Intervention Using Drug-Eluting Stents and Coronary Artery Bypass Grafting for Chronic Total Occlusion Revascularization
Authors: Hee-Soon Park, Jae-Hyung Roh, Pil Hyung Lee, Mineok Chang, Sung-Han Yoon, Jung-Min Ahn, Bong-Ki Lee, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2015)
Highlights
Journal: JAMA Psychiatry (2019)

Mild traumatic brain injury (mTBI) is a relatively common occurrence, but the mental health consequences are poorly understood.Stein and colleagues conducted a cohort study of 1155 patients with mTBI to examine mental health sequalae.Rates of posttraumatic stress disorder and major depressive disorder ranged from 9% to 19%, and some individuals, on the basis of education, race/ethnicity, and psychiatric history, were at substantially increased risk of mental health problems following mTBI.These findings highlight the importance of monitoring for mental health problems following mTBI, particularly for high-risk individuals.
Highlights
Authors: Howard Bauchner
Journal: JAMA (2016)

Chemoradiotherapy, Erlotinib in Advanced Pancreatic Cancer 1844In an open-label randomized trial that enrolled 449 patients with locally advanced pancreatic cancer that was controlled after induction chemotherapy, Hammel and colleagues found no signifi cant diff erence in overall survival with chemoradiotherapy vs chemotherapy alone and found no signifi cant diff erence in overall survival with gemcitabine vs gemcitabine plus erlotinib used as maintenance therapy.In an Editorial, Schrag discusses challenges in treating locally advanced pancreas cancer.
THE INFLUENCE OF HEREDITY IN TUBERCULOSIS
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Herz- und Gefässmittel, Diuretica und Specifica.
Journal: JAMA (1923)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Capgras' syndrome
Authors: R J Berson
Journal: American Journal of Psychiatry (1983)

Capgras' syndrome is the delusional belief in the existence of identical "doubles" of significant people in a patient's life, or of the patient himself or herself, or of both. It occurs in both men and women and in a variety of psychotic states. The author presents a review of 133 cases of Capgras' syndrome in the English-language literature, defining the syndrome in the light of Capgras' original reports as well as later descriptions, reviewing the discussions of both organic and functional causes, and suggesting in the context of a new case report a psychodynamic hypothesis that may provide a more adequate understanding and more effective treatment of the syndrome.
Elastoweb Bandages
Authors: MaryP. English, RogerR. M. Harman, Ruth Smith
Journal: British Journal of Dermatology (1971)

Journal Article Elastoweb Bandages Get access MaryP. English, MaryP. English The United Bristol Hospitals Search for other works by this author on: Oxford Academic Google Scholar RogerR. M. Harman, RogerR. M. Harman The United Bristol Hospitals Search for other works by this author on: Oxford Academic Google Scholar Ruth Smith Ruth Smith The United Bristol Hospitals Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 85, Issue 5, 1 November 1971, Page 499, https://doi.org/10.1111/j.1365-2133.1971.tb14070.x Published: 01 November 1971
This Week in &lt;EMPH&gt;JAMA&lt;/EMPH&gt;
Journal: JAMA (2004)

A. C. G. Voordouw, MD; M. C. J. M. Sturkenboom, PhD; J. P. Dieleman, PhD; Th. Stijnen, PhD; D. J. Smith, PhD; J. van der Lei, PhD; Bruno H. Ch. Stricker, MB, PhD
Correction
Journal: Circulation (2012)

corrections were needed: 1.On page 2591, in the first column, first paragraph under section "4.9.Periprocedural Myocardial Infarction Assessment," the last 2 lines of the Class I recommendation read, ". . .creatinine kinase-MB and troponin I or T should be measured. ..." They have been changed to read, ". . .creatine kinase-MB and/or troponin I or T should be measured. ..." The corrected recommendation now reads, In patients who have signs or symptoms suggestive of myocardial infarction during or after PCI or in asymptomatic patients with significant persistent angiographic complications (eg, large side-branch occlusion, flow-limiting dissection, no-reflow phenomenon, or coronary thrombosis), creatine kinase-MB and/or troponin I or T should be measured.(Level of Evidence: C). 2. On page 2591, in the first column, second paragraph under section "4.9.Periprocedural Myocardial Infarction Assessment," the parenthetical expression in the first and second lines of the Class IIb recommendation read, ". . .(creatinine kinase-MB and/or troponin I or T). ..." It has been changed to read, ". . .(creatine kinase-MB and/or troponin I or T). ..." The corrected recommendation now reads, Routine measurement of cardiac biomarkers (creatine kinase-MB and/or troponin I or T) in all patients after PCI may be reasonable.(Level of Evidence: C).
Letter: Heparin (continued)
Authors: Daniel Banes
Journal: JAMA (1974)

<h3>To the Editor.—</h3> The official<i>United States Pharmacopeia</i>monograph on heparin sodium provides an assay for standardizing the potency of the drug by comparing its capacity to prolong the clotting time of blood with that of USP sodium heparin reference standard. Protamines are not involved in this assay. The<i>USP</i>monograph further provides purity tests to preclude contaminating proteins, extraneous nitrogen content, pyrogens, and excessive acidity or alkalinity, volatile substances, and residue on ignition. Moreover,<i>USP</i>requires that the manufacturer label the product to indicate the organ and species from which it is derived. If improved standards, assay methods, purity tests, or labeling safeguards are available to enhance the clinical utility and efficiency of heparin sodium,<i>USP</i>should be pleased to receive explicit recommendations buttressed by verified scientific data.
Safer Sips: Removing Arsenic from Drinking Water
Authors: Karen Breslin
Journal: Environmental Health Perspectives (1998)

U.S. researchers are developing technologies that may someday protect millions of people worldwide whose drinking water is tainted with arsenic. Arsenic is released into water from soil and rock erosion, and is also a by-product of industrial processes including semiconductor manufacturing, petroleum refining, and mining and smelting operations.
Lehrbuch der Volksernährung nach dem Pirquet'schen System.
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Endoscopic and endosonographic staging in the management of cancer of the stomach and the esophagogastric junction.
Authors: G. Töppler, H. Röper, S. Cameron, L. Füzesi, A. Beham, G. Ramadori
Journal: Journal of Clinical Oncology (2011)

140 Background: Staging of the primary tumor in patients with advanced adenocarcinoma of the stomach or the esophagogastric junction under chemotherapy is not generally recommended [ESMO clinical recommendations; Ann Oncol 2009]. RECIST criteria do not detect local tumor regression adequately. Standards for endoscopic staging throughout therapy have not yet been established. Methods: Here we report on20 consecutive patients with locally advanced esophago or gastric adenocarcinoma which were treated with EOX or EOF (epirubicin, oxaliplatin, capecitabine or 5-FU). After two cycles of chemotherapy, therapeutic efficacy was assessed by gastroscopy (EGD), endosonography (EUS), ultrasonography (US) and CT-scan. EGD staging criteria included luminal occlusion, the aboral length of tumor involvement, tumor exulceration, formation of polypoid tissue or superficial ulcers, and gut motility. EUS-staging criteria included uT-staging of the different layers of the esophagogastric wall as well as of the adjacent lymph-nodes. Surgery was then performed within 2 to 4 weeks after the end of the third chemotherapy cycle. Results: In all patients, an early response to chemotherapy was observed by EGD and EUS, including regression of tumor size (length and depth), and appearance: former exulcerative tissue became rather polypoid and less vulnerable, and motility was regained in areas were tumor regression was observed. For the assessment of local tumor behaviour under chemotherapy, CT-scan was of limited help, as it was only able to monitor lymphadenopathy. Only in 3/20 cases there was a concordance between the EUS and CT-scan, as verified by histopathological review of the surgical specimen. Conclusions: EGD and EUS monitor early tumor response of the primary to chemotherapy adequately in all our cases of locally advanced esophago or gastric adenocarcinoma. Endoscopic measures are helpful for the assessment of early treatment response, and might help to direct therapeutic strategies. No significant financial relationships to disclose.
JAMA Neurology
Journal: JAMA Neurology (2020)

The mission of JAMA Neurology is to publish scientifi c information primarily important for those physicians caring for people with neurologic disorders but also for those interested in the structure and function of the normal and diseased nervous system.These specifi c aims are (1) to make timely publication of original research of the nervous system, (2) to record observations of single patients or groups of patients that will provide new information and insights,(3) to report more basic research that is pertinent to the understanding of disease, (4) to introduce topics of practice, ethics, teaching, and history that are useful, and (5) to provide a forum for discussion on topics that may be controversial in this fi eld.This information will be published only after extensive peer review so that originality, clarity, and precision are ensured.
P-235 Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC)
Authors: V. Ricci, D. Vivenza, M. Monteverde, G. Strola, C. Granetto, C. Lo Nigro, M.C. Merlano
Journal: Annals of Oncology (2015)